ReviewWorld journal of otorhinolaryngology - head and neck surgery2026
The Mechanism of NLRP3 Inflammasome Activation and Its Roles in Chronic Rhinosinusitis.
Review in World journal of otorhinolaryngology - head and neck surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
NLRP3 (NLR family pyrin domain containing 3) is one of the crucial receptors in pathogen recognition receptor (PRR) families which can recognize the pathogen-associated molecular patterns (PAMPs) and the damage-associated molecular patterns (DAMPs), thus triggering innate immune response. After NLRP3 activation, it recruits the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) and the effector protein caspase-1 (CASP-1) to form a multiprotein complex, which is named NLRP3 inflammasome, enables the cleavage of caspase-1. Furthermore, the active c-caspase-1 proteolytically cleaves GSDMD into N-GSDMD, which forms pores on the membrane, thus inducing the leakage of pro-inflammatory cytokines, including IL-1β and IL-18, which leads to lytic cell death, defined as pyroptosis. Recent studies suggest that the abnormal activation of NLRP3 inflammasome in human nasal epithelial cells, mucosal T lymphocytes, and mucosal macrophages is associated with the pathogenesis of chronic rhinosinusitis (CRS). However, the underlying mechanism is still unclear. To provide further perspective on how the NLRP3 inflammasome is activated in CRS, this review focuses on the structure-derived assembly and activation of the NLRP3 inflammasome, and its roles and the potential activation mechanism in CRS. We also discuss major cellular stress signals that trigger the NLRP3 inflammasome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.